At Svar Life Science, our unwavering commitment to quality and compliance drives us to meet the new IVDR standards. This dedication is crucial for maintaining the trust and confidence of our valued customers. Our internal teams have meticulously crafted action plans to secure all necessary ... Read more
Performance Insights and Support for a Smooth Transition We are excited to introduce our second-generation iLite® cells, designed to optimize your bioassay workflows and enhance data reliability. This blog post provides an in-depth look at the performance studies conducted on these new cell lines ... Read more
Introducing iLite® IFN FAST second-generation assay-ready cells Effective bioassays are crucial in pharmaceutical development for assessing potency and detecting neutralizing antibodies in immunogenicity studies. Our iLite IFN FAST second-generation cells offer shorter incubation times, Renilla ... Read more
Testing of GFAP in serum can provide valuable information in both traumatic brain injury and stroke. It is also helpful for certain neurodegenerative and neuroinflammatory conditions. We are now expanding our offering for GFAP by providing testing in serum. Additionally, serum and cerebrospinal ... Read more
